The University of Chicago Header Logo

Connection

Shyam Prabhakaran to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications Shyam Prabhakaran has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Shyam Prabhakaran
Connection Strength
1.180
Hydroxymethylglutaryl-CoA Reductase Inhibitors
  1. Statins for Neuroprotection After Acute Ischemic Stroke: ASSORTed Results But More Trials Needed. Stroke. 2017 11; 48(11):2922-2923.
    View in: PubMed
    Score: 0.420
  2. Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting. Stroke. 2017 08; 48(8):2158-2163.
    View in: PubMed
    Score: 0.412
  3. Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population. J Stroke Cerebrovasc Dis. 2025 Jul; 34(7):108349.
    View in: PubMed
    Score: 0.178
  4. Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities? J Stroke Cerebrovasc Dis. 2019 Nov; 28(11):104371.
    View in: PubMed
    Score: 0.120
  5. Experimental treatments for acute ischaemic stroke. Lancet. 2007 Jan 27; 369(9558):331-41.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.